Drug Trial Radar · NCT03439345
Lowering Events in Non-proliferative Retinopathy in Scotland
Last checked: Nov 20, 2026Latest source record: May 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,151
Actual
Start
Jul 23, 2018
Primary completion
Nov 17, 2023
Study completion Feb 16, 2024
Sponsor
- Lead sponsor
- University of OxfordAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute for Health Research, United Kingdom; University of Glasgow; University of Aberdeen; University of Dundee; University of Edinburgh; NHS Scotland Diabetic Retinopathy Screening Collaborative
- First posted
- Feb 20, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
LENS is a streamlined multicentre randomised placebo-controlled parallel-group trial investigating the effect of fenofibrate treatment on the progression of diabetic retinopathy/maculopathy.
Conditions
- Diabetic Retinopathy
Interventions
Fenofibrate 145 mgDrug
One tablet (taken daily with normal renal function, taken every second day with chronic kidney disease)
Placebo Oral TabletDrug
One tablet (taken daily with normal renal function, taken every second day with chronic kidney disease)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Progression to Referable Diabetic Retinopathy or Maculopathy, or TreatmentTime frame: 4.0 years (interquartile range, 3.6 to 4.3) years
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
NHS Grampian
Aberdeen, United Kingdom
NHS Lanarkshire
Airdrie, United Kingdom
NHS Ayrshire and Arran
Ayr, United Kingdom
NHS Dumfries and Galloway
Dumfries, United Kingdom
NHS Tayside
Dundee, United Kingdom
NHS Fife
Dunfermline, United Kingdom
NHS Lanarkshire
East Kilbride, United Kingdom
NHS Lothian
Edinburgh, United Kingdom
NHS Greater Glasgow and Clyde
Glasgow, United Kingdom
NHS Highland
Inverness, United Kingdom
NHS Ayrshire and Arran
Kilmarnock, United Kingdom
NHS Fife
Kirkcaldy, United Kingdom
NHS Forth Valley
Larbert, United Kingdom
NHS Borders
Melrose, United Kingdom
NHS Tayside
Perth, United Kingdom
NHS Lanarkshire
Wishaw, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.